uniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates

uniQure (QURE) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.93. This compares to a loss of $1.5 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +39.91%. A quarter ago, it was expected that this human gene therapy company would post a loss of $0.85 per share when it actually produced a loss of $1.38, delivering a surprise of -62.35%.Over the last four quarters, the compan ...